Treatment of Infection Due to Pneumocystis carinii

This publication has 73 references indexed in Scilit:

• Clindamycin/Primaquine as Prophylaxis for Pneumocystis carinii Pneumonia
  Clinical Infectious Diseases, 1996
• Intrapulmonary and Systemic Pharmacokinetics of Aerosolized Pentamidine Used for Prophylaxis of Pneumocystis carinii Pneumonia in Patients Infected with the Human Immunodeficiency Virus
  The Journal of Clinical Pharmacology, 1995
• Effect of corticosteroids on survival of children with acquired immunodeficiency syndrome and Pneumocystis carinii -related respiratory failure
  The Journal of Pediatrics, 1995
• A Randomized Trial of Three Antipneumocystis Agents in Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1995
• ChemInform Abstract: Pneumocandin D0, a New Antifungal Agent and Potent Inhibitor of Pneumocystis carinii.
  ChemInform, 1995
• Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses andPneumocystis carinii pneumonia in HIV-infected patients
  European Journal of Clinical Microbiology & Infectious Diseases, 1993
• Studies on the effects of several pentamidine analogues on the NMDA receptor
  European Journal of Pharmacology: Molecular Pharmacology, 1993
• Clindamycin/Primaquine Therapy and Secondary Prophylaxis Against Pneumocystis carinii Pneumonia in Patients With AIDS
  Southern Medical Journal, 1990
• Trimetrexate for the Treatment ofPneumocystis cariniiPneumonia in Patients with the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1987
• Comparison of pentamidine isethionate andtrimethoprim-sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia
  The Journal of Pediatrics, 1978